HC Wainwright Has Pessimistic Outlook of BCAX Q1 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Equities researchers at HC Wainwright cut their Q1 2025 earnings per share estimates for shares of Bicara Therapeutics in a research note issued to investors on Monday, April 7th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.40) per share for […]
